Shankman Michael Elliot

Shankman Michael Elliot is listed in filings as Chief Financial Officer at Lexaria Bioscience Corp.. This profile follows SEC Form 4 activity through May 16, 2025, including 1 public disclosure. Recent filings connect the profile to Lexaria Bioscience Corp. (LEXX). The current snapshot covers public activity from May 16, 2025. Reported amounts are shown as $52.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.